These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


87 related items for PubMed ID: 2766520

  • 1. Mechanisms responsible for inhibition of vein-graft arteriosclerosis by fish oil.
    Sarris GE, Fann JI, Sokoloff MH, Smith DL, Loveday M, Kosek JC, Stephens RJ, Cooper AD, May K, Willis AL.
    Circulation; 1989 Sep; 80(3 Pt 1):I109-23. PubMed ID: 2766520
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of vein graft intimal thickening by eicosapentanoic acid: reduced thromboxane production without change in lipoprotein levels or low-density lipoprotein receptor density.
    Cahill PD, Sarris GE, Cooper AD, Wood PD, Kosek JC, Mitchell RS, Miller DC.
    J Vasc Surg; 1988 Jan; 7(1):108-18. PubMed ID: 3336117
    [Abstract] [Full Text] [Related]

  • 3. Combined arachidonic acid and ADP platelet inhibition maximizes patency of small-diameter vascular grafts.
    Valentin LI, Sicard GA, Freeman MB, Allen BT, McGoff MA, Anderson CB.
    Surgery; 1988 Aug; 104(2):178-84. PubMed ID: 3135624
    [Abstract] [Full Text] [Related]

  • 4. Cod-liver oil in the prevention of intimal hyperplasia in autogenous vein grafts used for arterial bypass.
    Landymore RW, Kinley CE, Cooper JH, MacAulay M, Sheridan B, Cameron C.
    J Thorac Cardiovasc Surg; 1985 Mar; 89(3):351-7. PubMed ID: 3974270
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The effect of platelet inhibitory therapy on prosthetic graft maturation.
    Bearn PE, Moffat C, Seddon AM, Bull H, Marston A, Fox B, McCollum CN.
    Int J Exp Pathol; 1993 Feb; 74(1):1-8. PubMed ID: 8471529
    [Abstract] [Full Text] [Related]

  • 8. Reduction of intimal hyperplasia in canine autologous vein grafts with cod-liver oil and dipyridamole.
    Landymore RW, Cameron CA, Sheridan BL, MacAuley MA.
    Can J Surg; 1986 Sep; 29(5):357-8. PubMed ID: 3019497
    [Abstract] [Full Text] [Related]

  • 9. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
    Serebruany VL, Malinin AI, Pokov AN, Hanley DF.
    Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
    [Abstract] [Full Text] [Related]

  • 10. Effects of aspirin, dipyridamole, and cod liver oil on accelerated myointimal proliferation in canine veno-arterial allografts.
    DeCampli WM, Kosek JC, Mitchell RS, Handen CE, Miller DC.
    Ann Surg; 1988 Dec; 208(6):746-54. PubMed ID: 3196097
    [Abstract] [Full Text] [Related]

  • 11. Correlation between the effects of aspirin and dipyridamole on platelet function and prevention of intimal hyperplasia in autologous vein grafts.
    Landymore RW, Karmazyn M, MacAulay MA, Sheridan B, Cameron CA.
    Can J Cardiol; 1988 Dec; 4(1):56-9. PubMed ID: 3359354
    [Abstract] [Full Text] [Related]

  • 12. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [Abstract] [Full Text] [Related]

  • 13. Thrombosis and neointima formation in vein grafts are inhibited by locally applied aspirin through endothelial protection.
    Torsney E, Mayr U, Zou Y, Thompson WD, Hu Y, Xu Q.
    Circ Res; 2004 Jun 11; 94(11):1466-73. PubMed ID: 15117816
    [Abstract] [Full Text] [Related]

  • 14. Reduction in the incidence of thrombosis by the thromboxane synthetase inhibitor CGS 13080 in a canine model of coronary artery injury.
    Simpson PJ, Smith CB, Rosenthal G, Lucchesi BR.
    J Pharmacol Exp Ther; 1986 Aug 11; 238(2):497-501. PubMed ID: 3735129
    [Abstract] [Full Text] [Related]

  • 15. Combination of fish oil and fish protein hydrolysate reduces the plasma cholesterol level with a concurrent increase in hepatic cholesterol level in high-fat-fed Wistar rats.
    Wergedahl H, Gudbrandsen OA, Røst TH, Berge RK.
    Nutrition; 2009 Jan 11; 25(1):98-104. PubMed ID: 18752928
    [Abstract] [Full Text] [Related]

  • 16. Effect of MaxEPA (fish oil) on lipoproteins and its receptors in hypercholesterolemic rabbits.
    Achtani C, Awtade A, Vasisht S, Srivastava LM.
    Biochem Mol Biol Int; 1995 Oct 11; 37(3):489-98. PubMed ID: 8595389
    [Abstract] [Full Text] [Related]

  • 17. Effects of cod-liver oil on intimal hyperplasia in vein grafts used for arterial bypass.
    Landymore RW, MacAulay MA, Cooper JH, Sheridan BL.
    Can J Surg; 1986 Mar 11; 29(2):129-31. PubMed ID: 3006901
    [Abstract] [Full Text] [Related]

  • 18. The effect of platelet inhibitory therapy on graft thromboresistance.
    Bearn PE, Bull H, Seddon AM, Marston A, McCollum CN.
    Int J Exp Pathol; 1993 Oct 11; 74(5):425-31. PubMed ID: 8217777
    [Abstract] [Full Text] [Related]

  • 19. Both dietary fish-oil supplementation and aspirin fail to inhibit atherosclerosis in long-term vein bypass grafts in moderately hypercholesterolemic nonhuman primates.
    Boerboom LE, Olinger GN, Almassi GH, Skrinska VA.
    Circulation; 1997 Aug 05; 96(3):968-74. PubMed ID: 9264508
    [Abstract] [Full Text] [Related]

  • 20. Effects of dietary fish oil supplementation on cellular adhesion molecule expression and tissue myeloperoxidase activity in hypercholesterolemic mice with sepsis.
    Chiu WC, Wang YC, Chien YW, Hou YC, Hu YM, Yeh SL.
    J Nutr Biochem; 2009 Apr 05; 20(4):254-60. PubMed ID: 18602812
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.